結果ページ13 セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
すべての国
- {{country.name}}
- すべての国
- 米国 (1011)
- オーストラリア (58)
- オーストリア (16)
- ベルギー (7)
- ブラジル (16)
- カナダ (83)
- 中国 (94)
- デンマーク (6)
- フィンランド (4)
- フランス (41)
- ドイツ (737)
- 香港 (46)
- インド (19)
- アイルランド (1)
- イスラエル (19)
- イタリア (4)
- 日本 (37)
- メキシコ (28)
- オランダ (3)
- ニュージーランド (1)
- ノルウェー (14)
- ポーランド (9)
- ロシア (2)
- 韓国 (10)
- スペイン (4)
- スウェーデン (70)
- スイス (11)
- 台湾 (67)
- タイ (2)
- トルコ (1)
- イギリス (69)
全取引所
- {{item.name}}
- 全取引所
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (278)
- NasdaqGM (142)
- NasdaqGS (239)
- NSE (10)
- NYSE (10)
- NYSE American (20)
- NZSE (1)
- Oslo (14)
- Other OTC (322)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (38)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
バイオテクノロジー (2608)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| BridgeBio Pharma, Inc. 2CL.F | $23.34 25.51 USD |
-0.26
|
$4.43B 4.84B USD | $200 218.63 USD | $23.34 25.51 USD | $23.34 25.51 USD | $4.43B 4.84B USD | 0 | -$3.02 -3.3 USD | |
| SK Biopharmaceuticals Co., Ltd. 326030.KS | $78,900 59.56 USD |
+1.81
|
$6.18T 4.66B USD | $80.62K 60.85 USD | $76,500 57.75 USD | $79,300 59.86 USD | $6.18T 4.66B USD | 0 | $0 0 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $35.1 38.37 USD |
-8.03
|
$4.26B 4.66B USD | $20 21.86 USD | $34.33 37.52 USD | $35.1 38.37 USD | $4.26B 4.66B USD | 0 | -$3.2 -3.4 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
| Alpine Immune Sciences ALPN | $64.97 — |
0
|
$4.46B — | $0 — | $0 — | $0 — | $4.46B — | 0 | $0 — | |
| ALK-Abelló A/S 0OIR.IL | $150.4 22.05 USD |
+0.64
|
$30.19B 4.43B USD | $562 82.4 USD | $150.4 22.05 USD | $151.4 22.2 USD | $30.19B 4.43B USD | 93.41 | $1.61 0.24 USD | |
| ImmunityBio, Inc. 26CA.F | $5.64 6.17 USD |
-3.06
|
$3.94B 4.31B USD | $300 327.94 USD | $5.64 6.17 USD | $5.65 6.17 USD | $3.94B 4.31B USD | 0 | -$1.01 -1.1 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Mirati Therapeutics MRTX | $58.7 — |
0
|
$4.12B — | $0 — | $0 — | $0 — | $4.12B — | 0 | $0 — | |
| Akeso, Inc. 4RY.F | $4.28 4.68 USD |
-4.46
|
$3.73B 4.08B USD | $360 393.53 USD | $4.28 4.68 USD | $4.28 4.68 USD | $3.73B 4.08B USD | 13.80 | $0.31 0.34 USD | |
| Merus N.V. 2GH.F | $54.5 59.58 USD |
-1.8
|
$3.67B 4.01B USD | $30 32.79 USD | $54 59.03 USD | $54.5 59.58 USD | $3.67B 4.01B USD | 0 | -$2.55 -2.7 USD | |
| Axsome Therapeutics, Inc. 19X.F | $75.6 82.64 USD |
+2.13
|
$3.65B 3.99B USD | $10 10.93 USD | $73.9 80.78 USD | $75.6 82.64 USD | $3.65B 3.99B USD | 0 | -$6.03 -6.5 USD | |
| BB Biotech AG BB.MI | $65.2 71.27 USD |
0
|
$3.58B 3.91B USD | $10.08K 11.02K USD | $51.6 56.41 USD | $52.9 57.83 USD | $3.58B 3.91B USD | 5.75 | $11.32 12.37 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $38.2 41.76 USD |
-1.04
|
$3.46B 3.78B USD | $21 22.96 USD | $38.2 41.76 USD | $38.2 41.76 USD | $3.46B 3.78B USD | 0 | -$7.42 -8.1 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| CymaBay Therapeutics CBAY | $32.48 — |
0
|
$3.73B — | $0 — | $0 — | $0 — | $3.73B — | 0 | $0 — | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $41.4 45.26 USD |
+1.97
|
$3.36B 3.68B USD | $40 43.73 USD | $41.4 45.26 USD | $41.4 45.26 USD | $3.36B 3.68B USD | 0 | -$3.52 -3.8 USD | |
| Syngene International Limited SYNGENE.BO | $716.05 8.66 USD |
+0.88
|
$287.35B 3.48B USD | $40.06K 484.65 USD | $710 8.59 USD | $726 8.78 USD | $287.35B 3.48B USD | 56.33 | $12.71 0.15 USD | |
| Corcept Therapeutics Incorporated HTD.F | $29.91 32.7 USD |
+0.07
|
$3.16B 3.46B USD | $50 54.66 USD | $29.91 32.7 USD | $29.91 32.7 USD | $3.16B 3.46B USD | 30.52 | $0.98 1.07 USD | |
| Denali Therapeutics Inc. 4DN.MU | $21.48 23.48 USD |
+0.66
|
$3.11B 3.4B USD | $74 80.89 USD | $21.48 23.48 USD | $21.48 23.48 USD | $3.11B 3.4B USD | 0 | -$0.88 -0.9 USD | |
| Camurus AB (publ) 7CA.F | $53.3 58.26 USD |
+2.4
|
$3.11B 3.4B USD | $58 63.4 USD | $53.3 58.26 USD | $53.3 58.26 USD | $3.11B 3.4B USD | 77.24 | $0.69 0.75 USD | |
| Denali Therapeutics Inc. 4DN.F | $21.49 23.49 USD |
+0.51
|
$3.11B 3.4B USD | $22 24.05 USD | $21.49 23.49 USD | $21.49 23.49 USD | $3.11B 3.4B USD | 0 | -$0.88 -0.9 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $24.01 26.25 USD |
+0.67
|
$3.03B 3.31B USD | $20 21.86 USD | $24.01 26.25 USD | $24.01 26.25 USD | $3.03B 3.31B USD | 0 | -$3.95 -4.3 USD | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $5.5 6.01 USD |
-0.9
|
$3.02B 3.3B USD | $38 41.54 USD | $5.5 6.01 USD | $5.5 6.01 USD | $3.02B 3.3B USD | 8.08 | $0.68 0.74 USD | |
| Galapagos NV GXE.DE | $44.47 48.61 USD |
0
|
$2.93B 3.2B USD | $1 1.09 USD | $44.18 48.29 USD | $44.47 48.61 USD | $2.93B 3.2B USD | 0 | -$1.92 -2.09 USD | |
| SK bioscience Co.,Ltd. 302440.KS | $53,800 40.61 USD |
+2.28
|
$4.13T 3.12B USD | $202.48K 152.84 USD | $52,300 39.48 USD | $54,200 40.91 USD | $4.13T 3.12B USD | 0 | $0 0 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $36.2 39.57 USD |
+3.43
|
$2.85B 3.11B USD | $20 21.86 USD | $36.2 39.57 USD | $36.2 39.57 USD | $2.85B 3.11B USD | 0 | -$2.54 -2.7 USD | |
| VitaSpring Biomedical VSBC | $15 — |
0
|
$3.1B — | $242 — | $15 — | $15 — | $3.1B — | 0 | $0 — | |
| Amicus Therapeutics, Inc. AM6.F | $9.1 9.95 USD |
-0.55
|
$2.73B 2.98B USD | $850 929.16 USD | $9.1 9.95 USD | $9.1 9.95 USD | $2.73B 2.98B USD | 0 | -$0.46 -0.5 USD | |
| MorphoSys AG MOR.VI | $67.7 74.01 USD |
-0.15
|
$2.55B 2.79B USD | $0 0 USD | $67.7 74.01 USD | $67.8 74.11 USD | $2.55B 2.79B USD | 0 | -$5.53 -6.04 USD | |
| MorphoSys AG MOR2.F | $16.5 18.04 USD |
0
|
$2.55B 2.78B USD | $40 43.73 USD | $16.5 18.04 USD | $16.5 18.04 USD | $2.55B 2.78B USD | 0 | -$1.38 -1.5 USD | |
| MorphoSys AG MOR.F | $67.6 73.9 USD |
0
|
$2.55B 2.78B USD | $3 3.28 USD | $67.35 73.62 USD | $67.75 74.06 USD | $2.55B 2.78B USD | 0 | -$5.53 -6.04 USD | |
| TG Therapeutics, Inc. NKB2.F | $16.39 17.91 USD |
-1.53
|
$2.53B 2.77B USD | $250 273.28 USD | $16.39 17.91 USD | $16.39 17.91 USD | $2.53B 2.77B USD | 58.52 | $0.28 0.31 USD | |
| IDEAYA Biosciences, Inc. 30J.SG | $31.6 34.54 USD |
+1.28
|
$2.51B 2.75B USD | $0 0 USD | $31.6 34.54 USD | $31.6 34.54 USD | $2.51B 2.75B USD | 0 | -$1.87 -2.04 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $32.4 35.42 USD |
+1.25
|
$2.51B 2.75B USD | $420 459.12 USD | $32.4 35.42 USD | $32.4 35.42 USD | $2.51B 2.75B USD | 0 | -$1.87 -2.04 USD | |
| MorphoSys AG MPSYF | $71.76 — |
+0.53
|
$2.73B — | $100 — | $71.76 — | $71.76 — | $2.73B — | 0 | -$5.91 — | |
| ACADIA Pharmaceuticals Inc. DR6.F | $15.03 16.42 USD |
-1.25
|
$2.48B 2.71B USD | $180 196.76 USD | $15.03 16.42 USD | $15.03 16.42 USD | $2.48B 2.71B USD | 0 | $0 0 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $37.8 41.32 USD |
+1.07
|
$2.36B 2.58B USD | $50 54.66 USD | $37.4 40.88 USD | $37.4 40.88 USD | $2.36B 2.58B USD | 0 | -$4.32 -4.7 USD | |
| Geron Corporation GON.F | $3.89 4.25 USD |
-7.03
|
$2.31B 2.52B USD | $30 32.79 USD | $3.89 4.25 USD | $3.89 4.25 USD | $2.31B 2.52B USD | 0 | -$0.32 -0.3 USD | |
| BB Biotech AG Ord BBZA.F | $41.1 44.93 USD |
-1.08
|
$2.26B 2.47B USD | $765 836.25 USD | $41.1 44.93 USD | $42 45.91 USD | $2.26B 2.47B USD | 7.04 | $5.83 6.37 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $39.8 43.51 USD |
-1.49
|
$2.26B 2.47B USD | $40 43.73 USD | $39.8 43.51 USD | $39.8 43.51 USD | $2.26B 2.47B USD | 0 | -$5.89 -6.4 USD | |
| Celldex Therapeutics, Inc. TCE2.F | $34.2 37.39 USD |
-2.84
|
$2.25B 2.46B USD | $19 20.77 USD | $34.2 37.39 USD | $34.2 37.39 USD | $2.25B 2.46B USD | 0 | -$2.67 -2.9 USD | |
| Bavarian Nordic A/S 0DPB.IL | $173.15 25.39 USD |
-0.24
|
$16.25B 2.38B USD | $2.97K 435.32 USD | $171.45 25.14 USD | $174 25.51 USD | $16.25B 2.38B USD | 12.28 | $14.09 2.07 USD | |
| Iovance Biotherapeutics, Inc. 2LB.F | $7.48 8.17 USD |
+0.51
|
$2.1B 2.3B USD | $200 218.63 USD | $7.48 8.17 USD | $7.48 8.17 USD | $2.1B 2.3B USD | 0 | -$1.69 -1.8 USD | |
| Rocket Pharmaceuticals, Inc. 9IP1.F | $19.65 21.48 USD |
+15.05
|
$2.1B 2.3B USD | $100 109.31 USD | $19.65 21.48 USD | $19.65 21.48 USD | $2.1B 2.3B USD | 0 | -$2.66 -2.9 USD | |
| Genscript Biotech Corporation G51.F | $0.9699 1.06 USD |
-1.02
|
$2.09B 2.29B USD | $1K 1.09K USD | $0.9699 1.06 USD | $0.9699 1.06 USD | $2.09B 2.29B USD | 0 | -$0.04 -0.04 USD | |
| Vericel Corporation ATQP.F | $42.4 46.35 USD |
-2.75
|
$2.06B 2.25B USD | $5 5.47 USD | $42.4 46.35 USD | $42.4 46.35 USD | $2.06B 2.25B USD | 4240.00 | $0.01 0.01 USD | |
| BioArctic AB (publ) 0RV2.IL | $229 22.35 USD |
+0.84
|
$22.91B 2.24B USD | $140 13.67 USD | $228.2 22.28 USD | $229 22.35 USD | $22.91B 2.24B USD | 74.59 | $3.07 0.3 USD | |
| Bavarian Nordic A/S BV3.DE | $25.3 27.66 USD |
0
|
$1.99B 2.18B USD | $661 722.56 USD | $25 27.33 USD | $25.73 28.13 USD | $1.99B 2.18B USD | 45.17 | $0.56 0.61 USD | |
| Intellia Therapeutics, Inc. 38I.F | $20.32 22.21 USD |
-2.82
|
$1.96B 2.14B USD | $35 38.26 USD | $19.94 21.8 USD | $20.34 22.23 USD | $1.96B 2.14B USD | 0 | -$5.01 -5.4 USD | |
| 3SBio Inc. 83B.F | $0.7099 0.78 USD |
+2.9
|
$1.9B 2.08B USD | $1K 1.09K USD | $0.7099 0.78 USD | $0.7099 0.78 USD | $1.9B 2.08B USD | 8.87 | $0.08 0.09 USD | |
| Novavax, Inc. NVAX.MX | $229 13.56 USD |
-2.84
|
$34.39B 2.04B USD | $0 0 USD | $0 0 USD | $0 0 USD | $34.39B 2.04B USD | 0 | -$56.24 -3.3 USD | |
| PeptiDream PPTDF | $14.3 — |
0
|
$2.01B — | $200 — | $14.3 — | $14.3 — | $2.01B — | 119.16 | $0.12 — | |
| Ardelyx, Inc. 41X.F | $6.77 7.4 USD |
+12.83
|
$1.82B 1.99B USD | $120 131.18 USD | $6.77 7.4 USD | $6.77 7.4 USD | $1.82B 1.99B USD | 0 | -$0.26 -0.2 USD | |
| Bavarian Nordic A/S BV3.F | $23.06 25.21 USD |
-0.13
|
$1.8B 1.97B USD | $1.18K 1.29K USD | $22.96 25.1 USD | $23.78 25.99 USD | $1.8B 1.97B USD | 13.64 | $1.69 1.85 USD | |
| BioArctic AB (publ) B9A.F | $20.12 21.99 USD |
+1.16
|
$1.79B 1.96B USD | $95 103.85 USD | $20.12 21.99 USD | $20.12 21.99 USD | $1.79B 1.96B USD | 0 | -$0.12 -0.1 USD | |
| Bavarian Nordic A/S BVNRY | $8.26 — |
-7.81
|
$1.93B — | $1.3K — | $8.26 — | $8.33 — | $1.93B — | 13.76 | $0.6 — | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $14.21 15.53 USD |
+2.6
|
$1.75B 1.92B USD | $2K 2.19K USD | $14.21 15.53 USD | $14.21 15.53 USD | $1.75B 1.92B USD | 27.32 | $0.52 0.57 USD | |
| Galapagos GLPGF | $26.2 — |
-27.62
|
$1.9B — | $190 — | $26.2 — | $26.2 — | $1.9B — | 52.39 | $0.5 — | |
| Maravai LifeSciences Holdings, Inc. MAR.F | $6.6 7.21 USD |
0
|
$1.69B 1.85B USD | $500 546.57 USD | $6.6 7.21 USD | $6.6 7.21 USD | $1.69B 1.85B USD | 0 | -$0.92 -1.005 USD | |
| Galapagos NV G1LP34.SA | $6.99 1.42 USD |
+1.6
|
$9.06B 1.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $9.06B 1.84B USD | 2.52 | $2.77 0.56 USD | |
| Shanghai Haohai Biological Technology Co., Ltd. 5HB.F | $3.72 4.07 USD |
-0.53
|
$1.67B 1.83B USD | $290 317.01 USD | $3.72 4.07 USD | $3.72 4.07 USD | $1.67B 1.83B USD | 16.17 | $0.23 0.25 USD | |
| Fusion Pharmaceuticals FUSN | $21.41 — |
0
|
$1.82B — | $0 — | $0 — | $0 — | $1.82B — | 0 | $0 — | |
| Syndax Pharmaceuticals, Inc. 1T3.F | $18.7 20.44 USD |
+0.54
|
$1.64B 1.79B USD | $100 109.31 USD | $18.7 20.44 USD | $18.7 20.44 USD | $1.64B 1.79B USD | 0 | -$3.03 -3.3 USD | |
| Ambrx Biopharma AMAM | $28 — |
0
|
$1.77B — | $0 — | $0 — | $0 — | $1.77B — | 0 | $0 — | |
| Bavarian Nordic A/S BVNKF | $21.2 — |
0
|
$1.77B — | $1 — | $21.2 — | $21.2 — | $1.77B — | 11.77 | $1.8 — | |
| Immunocore Holdings plc 6YG.F | $31 33.89 USD |
-0.64
|
$1.57B 1.72B USD | $100 109.31 USD | $31 33.89 USD | $31 33.89 USD | $1.57B 1.72B USD | 0 | -$1.44 -1.5 USD | |
| Zai Lab Limited 1ZL.F | $15.8 17.27 USD |
-1.86
|
$1.57B 1.71B USD | $25 27.33 USD | $15.8 17.27 USD | $15.8 17.27 USD | $1.57B 1.71B USD | 0 | -$3.27 -3.5 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $31.4 34.32 USD |
+3.97
|
$1.56B 1.71B USD | $6 6.56 USD | $31.4 34.32 USD | $31.4 34.32 USD | $1.56B 1.71B USD | 0 | -$3.49 -3.8 USD | |
| Neuren Pharmaceuticals NURPF | $13.15 — |
0
|
$1.71B — | $100 — | $13.15 — | $13.15 — | $1.71B — | 16.43 | $0.8 — | |
| Morphic Holding, Inc. 31Y.F | $30.8 33.67 USD |
-1.91
|
$1.56B 1.71B USD | $750 819.85 USD | $30.6 33.45 USD | $30.8 33.67 USD | $1.56B 1.71B USD | 0 | -$3.36 -3.6 USD | |
| Galapagos NV GXE.F | $23.3 25.47 USD |
+1.22
|
$1.56B 1.7B USD | $120 131.18 USD | $23.3 25.47 USD | $23.3 25.47 USD | $1.56B 1.7B USD | 49.57 | $0.47 0.51 USD | |
| Immunocore Holdings plc 6YG.MU | $31 33.89 USD |
0
|
$1.55B 1.69B USD | $13 14.21 USD | $31 33.89 USD | $31 33.89 USD | $1.55B 1.69B USD | 0 | -$1.32 -1.4 USD | |
| Galapagos NV GLPG.VI | $23.34 25.51 USD |
-0.51
|
$1.54B 1.68B USD | $0 0 USD | $23.46 25.64 USD | $23.46 25.64 USD | $1.54B 1.68B USD | 49.65 | $0.47 0.51 USD | |
| Akero Therapeutics, Inc. 0K4.F | $21.59 23.6 USD |
+1.36
|
$1.54B 1.68B USD | $1.68K 1.83K USD | $21.59 23.6 USD | $21.59 23.6 USD | $1.54B 1.68B USD | 0 | -$3.03 -3.3 USD | |
| Agios Pharmaceuticals, Inc. AGIO.MX | $397.93 23.56 USD |
0
|
$28.11B 1.66B USD | $0 0 USD | $397.93 23.56 USD | $397.93 23.56 USD | $28.11B 1.66B USD | 0 | -$105.76 -6.2 USD | |
| Veracyte, Inc. 12V.F | $19.9 21.75 USD |
-4.33
|
$1.52B 1.66B USD | $7 7.65 USD | $19.9 21.75 USD | $19.9 21.75 USD | $1.52B 1.66B USD | 0 | -$0.87 -0.9 USD | |
| Galapagos NV GXEA.F | $22.8 24.92 USD |
-1.72
|
$1.51B 1.65B USD | $386 421.95 USD | $22.8 24.92 USD | $22.8 24.92 USD | $1.51B 1.65B USD | 48.51 | $0.47 0.51 USD | |
| Kura Oncology, Inc. KUR.F | $18.98 20.74 USD |
0
|
$1.47B 1.6B USD | $50 54.66 USD | $18.98 20.74 USD | $18.98 20.74 USD | $1.47B 1.6B USD | 0 | -$2.03 -2.2 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $78 85.26 USD |
+1.3
|
$1.43B 1.56B USD | $1 1.09 USD | $78 85.26 USD | $78 85.26 USD | $1.43B 1.56B USD | 15.59 | $5 5.47 USD | |
| Biotest Aktiengesellschaft BIO.F | $41.8 45.69 USD |
+2.45
|
$1.4B 1.53B USD | $100 109.31 USD | $41.8 45.69 USD | $41.8 45.69 USD | $1.4B 1.53B USD | 9.35 | $4.47 4.89 USD | |
| Biotest Aktiengesellschaft BIO3.F | $26.4 28.86 USD |
+0.76
|
$1.37B 1.5B USD | $120 131.18 USD | $26.4 28.86 USD | $26.4 28.86 USD | $1.37B 1.5B USD | 5.90 | $4.47 4.89 USD | |
| Biotest Aktiengesellschaft BIO3.VI | $26.7 29.19 USD |
+0.75
|
$1.37B 1.5B USD | $0 0 USD | $26.5 28.97 USD | $26.8 29.3 USD | $1.37B 1.5B USD | 5.97 | $4.47 4.89 USD | |
| Biotest Aktiengesellschaft BIO3.DE | $26.9 29.41 USD |
+0.75
|
$1.37B 1.5B USD | $200 218.63 USD | $26.9 29.41 USD | $26.9 29.41 USD | $1.37B 1.5B USD | 6.01 | $4.47 4.89 USD | |
| Biotest Aktiengesellschaft BIO.DE | $42.2 46.13 USD |
0
|
$1.36B 1.49B USD | $122 133.36 USD | $42.2 46.13 USD | $42.2 46.13 USD | $1.36B 1.49B USD | 9.44 | $4.47 4.89 USD | |
| MannKind Corporation NNFN.F | $4.94 5.4 USD |
+0.98
|
$1.34B 1.47B USD | $200 218.63 USD | $4.79 5.24 USD | $4.94 5.4 USD | $1.34B 1.47B USD | 123.40 | $0.04 0.04 USD | |
| Genus GENSF | $22 — |
0
|
$1.46B — | $1K — | $22 — | $22 — | $1.46B — | 34.37 | $0.64 — | |
| Lexicon Pharmaceuticals, Inc. LX31.MU | $3.53 3.86 USD |
0
|
$1.28B 1.39B USD | $250 273.28 USD | $3.53 3.86 USD | $3.53 3.86 USD | $1.28B 1.39B USD | 0 | -$0.55 -0.6 USD | |
| Vir Biotechnology, Inc. VIR.MX | $172 10.18 USD |
0
|
$23.4B 1.39B USD | $0 0 USD | $172 10.18 USD | $172 10.18 USD | $23.4B 1.39B USD | 0 | -$78.1 -4.6 USD | |
| Genus plc GBE.F | $18.9 20.66 USD |
-2.07
|
$1.26B 1.38B USD | $100 109.31 USD | $18.9 20.66 USD | $18.9 20.66 USD | $1.26B 1.38B USD | 31.49 | $0.6 0.66 USD | |
| Bicycle Therapeutics plc 50BA.F | $18 19.68 USD |
-4.76
|
$1.24B 1.36B USD | $230 251.42 USD | $18 19.68 USD | $18 19.68 USD | $1.24B 1.36B USD | 0 | -$4.11 -4.4 USD | |
| POINT Biopharma Global PNT | $12.5 — |
0
|
$1.33B — | $0 — | $0 — | $0 — | $1.33B — | 0 | $0 — | |
| BioCryst Pharmaceuticals, Inc. BO1.F | $5.7 6.24 USD |
+0.74
|
$1.2B 1.31B USD | $500 546.57 USD | $5.7 6.23 USD | $5.71 6.24 USD | $1.2B 1.31B USD | 0 | -$1 -1.09 USD | |
| Immatics N.V. 4A3.F | $10.95 11.97 USD |
+1.3
|
$1.13B 1.24B USD | $100 109.31 USD | $10.95 11.97 USD | $10.95 11.97 USD | $1.13B 1.24B USD | 0 | -$0.98 -1.07 USD | |
| Verona Pharma plc I9SA.F | $13.6 14.87 USD |
-2.86
|
$1.1B 1.21B USD | $75 81.99 USD | $13.6 14.87 USD | $13.6 14.87 USD | $1.1B 1.21B USD | 0 | -$0.75 -0.8 USD | |
| CTI BioPharma CTIC | $9.07 — |
0
|
$1.2B — | $0 — | $0 — | $0 — | $1.2B — | 0 | $0 — | |
| Xencor, Inc. XE9.F | $17.2 18.8 USD |
-2.82
|
$1.06B 1.16B USD | $300 327.94 USD | $17.2 18.8 USD | $17.3 18.91 USD | $1.06B 1.16B USD | 0 | -$2.03 -2.2 USD | |
| EQRx EQRX | $2.34 — |
0
|
$1.14B — | $0 — | $0 — | $0 — | $1.14B — | 0 | $0 — | |
| Prothena Corporation plc 0PT.F | $19 20.77 USD |
0
|
$1.04B 1.13B USD | $260 284.22 USD | $19 20.77 USD | $19 20.77 USD | $1.04B 1.13B USD | 0 | -$3 -3.2 USD | |
| Ocular Therapeutix, Inc. 0OT.F | $6.29 6.87 USD |
+0.7
|
$996.35M 1.09B USD | $500 546.57 USD | $6.24 6.83 USD | $6.24 6.83 USD | $996.35M 1.09B USD | 0 | -$1.05 -1.1 USD | |
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
||||||||||